North America Hereditary Cancer Testing Market Size, Share, and Analysis by 2027
North America Hereditary Cancer Testing Market to 2027 - Regional Analysis and Forecasts by Diagnosis Type (Biopsy, Imaging); Technology (Sequencing, PCR, Microarray); End User (Hospital, Clinics, Diagnostic Centers), and Country
- Report Date : Oct 2019
- Report Code : TIPRE00006806
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 132
The North America hereditary cancer testing market is expected to reach US$ 3,247.37 Mn in 2027 from US$ 1,255.79 Mn in 2018. The market is estimated to grow with a CAGR of 11.6% from 2019-2027.
The growth of the market is driven by factors such as, growing awareness about hereditary cancer and favorable reimbursement scenario. However, market growth is likely to slow down due to the gender gap in cancer genetic testing in the region.
Personalized medicines is a comparatively new idea that allows doctors to select medication based on a patient's hereditary profile; it is a developing area in the healthcare sector. The method not only reduces adverse side effects but also manages to produce strong results in a short period. For instance, mutations in BRCA1 and BRCA2 lead to breast cancer. However, identifying the type of variation in the breast cancer patient provides crucial information for the kind of treatment. Hence, personalized medicines allow right treatment at the right time, which reduces the mortality rate. On the back of these advantages, the personalized medicine approach is likely to create many opportunities for the hereditary cancer testing market players.
The US is expected to lead the market in the North America region to the rapidly increasing expenditure of research and development by biopharmaceutical companies. Moreover, various biopharmaceutical companies are focusing on the development of new cancer panel and direct to consumer test. Therefore, considering the factors mentioned above, growth of the market in the US is likely to contribute the most significant share in the North America region during the forecast period.
Mexico Hereditary cancer testing Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA HEREDITARY CANCER TESTING – MARKET SEGMENTATION
BY DIAGNOSIS TYPE
- Biopsy
- Blood Sample
- Cheek Swab Sample
- Imaging
BY TECHNOLOGY
- Sequencing
- PCR
- Microarray
BY END USER
- Diagnostic Centers
- Hospital
- Clinics
Company Profiles
- Biosero Inc.
- Hologic Inc.
- Koninklijke Philips N.V.
- Quest Diagnostics Incorporated
- Myriad Genetics, Inc.
- Cancer Genetics Inc.
- Invitae Corporation
- Myogenes
- Strand Life Sciences Pvt. Ltd.
- Pathway Genomics Corporation
- CENTOGENE AG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Diagnosis Type, Technology, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
2. North America Hereditary Cancer Testing Market – Key Takeaways
3. North America Hereditary Cancer Testing Market – Market Landscape
3.1 Overview
3.2 Market Segmentation
3.2.1 Global Hereditary Cancer Testing Market – By Diagnosis Type
3.2.2 Global Hereditary Cancer Testing Market – By Technology
3.2.3 Global Hereditary Cancer Testing Market – By End User
3.2.4 North America Hereditary Cancer Testing Market – By Country
3.3 PEST Analysis
4. North America Hereditary Cancer Testing Market - Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Favourable Reimbursement Scenario
4.1.2 Growing Awareness About Hereditary Cancer
4.2 Key Market Restraints
4.2.1 Gender Gap In Cancer Genetic Test
4.3 Key Market Opportunities
4.3.1 Whole Genome Sequencing (WGS) for Cancer
4.4 Future Trends
4.4.1 Demand For Personalized Medicines
4.5 Impact Analysis
5. Hereditary Cancer Testing Market – North America Analysis
5.1 North America Hereditary Cancer Testing Market Revenue Forecasts And Analysis
5.2 Performance of Key Players
6. North America Hereditary Cancer Testing Market Analysis – By Diagnosis Type
6.1 Overview
6.2 North America Hereditary Cancer Testing Market by Diagnosis Type, 2018 & 2027 (%)
6.3 North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Diagnosis Type (US$ Mn)
6.4 Biopsy Market
6.4.1 Overview
6.4.2 North America Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.3 Blood Sample Market
6.4.3.1 Overview
6.4.3.2 North America Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)
6.4.4 Cheek Swab Sample Market
6.4.4.1 Overview
6.4.4.2 North America Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)
6.5 Imaging Market
6.5.1 Overview
6.5.2 North America Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
7. North America Hereditary Cancer Testing Market Analysis – By Technology
7.1 Overview
7.2 North America Hereditary Cancer Testing Market by Technology, 2018 & 2027 (%)
7.3 North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
7.4 Sequencing Market
7.4.1 Overview
7.4.2 North America Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Polymerase Chain Reaction (PCR) Market
7.5.1 Overview
7.5.2 North America Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Microarray Market
7.6.1 Overview
7.6.2 North America Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Hereditary Cancer Testing Market Analysis – By End User
8.1 Overview
8.2 North America Hereditary Cancer Testing Market by End User, 2018 & 2027 (%)
8.3 North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
8.4 Diagnostic Centers Market
8.4.1 Overview
8.4.2 North America Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Hospitals Market
8.5.1 Overview
8.5.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Clinics Market
8.6.1 Overview
8.6.2 North America Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027
9.1.1 Overview
9.1.2 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.3 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
9.1.3.1 North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
9.1.4 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
9.1.5 North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.6 North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
9.1.7 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
9.1.7.2.1 US Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
9.1.7.3 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
9.1.7.4 US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.8 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.1 Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.8.2 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
9.1.8.2.1 Canada Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
9.1.8.3 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
9.1.8.4 Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
9.1.9 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.1 Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.9.2 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
9.1.9.2.1 Mexico Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)
9.1.9.3 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
9.1.9.4 Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
10. Hereditary Cancer Testing Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
10.3 Organic Growth Strategies
10.3.1 Overview
10.3.2 Product Launch
10.3.3 Product Approval
10.3.4 Others
10.4 Inorganic Growth Strategies
10.4.1 Overview
10.4.2 Partnership
10.4.3 Agreement & Collaboration
10.4.4 Acquisition
11. Hereditary Cancer Testing Market–Key Company Profiles
11.1 Hologic Inc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Financial Overview
11.1.4 Product Portfolio
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Koninklijke Philips N.V.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Financial Overview
11.2.4 Product Portfolio
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Quest Diagnostics Incorporated
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Financial Overview
11.3.4 Product Portfolio
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Myriad Genetics, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Financial Overview
11.4.4 Product Portfolio
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Cancer Genetics Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Financial Overview
11.5.4 Product Portfolio
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Invitae Corporation
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Financial Overview
11.6.4 Product Portfolio
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Myogenes
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Financial Overview
11.7.4 Product Portfolio
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Strand Life Sciences Pvt. Ltd.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Financial Overview
11.8.4 Product Portfolio
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Pathway Genomics Corporation
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Financial Overview
11.9.4 Product Portfolio
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 CENTOGENE AG
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Financial Overview
11.10.4 Product Portfolio
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary Of Terms
12.3 Methodology
12.3.1 Coverage
12.3.2 Secondary Research
12.3.3 Primary Research
LIST OF TABLES
Table 1. R&D Investments by Major Pharmaceutical Companies
Table 2. R&D Investments by PhRMA member companies,2016
Table 3. Number of Registered Studies for Clinical Trials
Table 4. Consolidation Across the CRO Industry
Table 5. North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Diagnosis Type (US$ Mn)
Table 6. North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Technology (US$ Mn)
Table 7. North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By End User (US$ Mn)
Table 8. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 9. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 10. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 11. North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 12. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 13. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 14. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 15. US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 16. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 17. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 18. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 19. Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 20. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)
Table 21. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)
Table 22. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)
Table 23. Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)
Table 24. Recent Product Launch in the Hereditary Cancer Testing Market
Table 25. Recent Product Approval in the Hereditary Cancer Testing Market
Table 26. Recent Other Growth Strategies in the Hereditary Cancer Testing Market
Table 27. Partnerships in the Hereditary Cancer Testing Market
Table 28. Agreement & Collaboration in the Hereditary Cancer Testing Market
Table 29. Acquisitions in the Hereditary Cancer Testing Market
Table 30. Glossary of Terms, Hereditary Cancer Testing Management Market
LIST OF FIGURES
Figure 1. US Hereditary Cancer Testing Market, Revenue (US$ Mn), By Country 2018 & 2027
Figure 2. North America Hereditary Cancer Testing Market By Diagnosis Type , Market Share (%), 2018
Figure 3. North America Hereditary Cancer Testing Market By Technology, Market Share (%), 2018
Figure 4. North America Hereditary Cancer Testing Market By End User, Market Share (%), 2018
Figure 5. Hereditary Cancer Testing Market Segmentation
Figure 6. North America PEST Analysis
Figure 7. Hereditary Cancer Testing Market Impact Analysis of Drivers & Restraints
Figure 8. North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 9. Prominent Players in the Hereditary Cancer Testing Market
Figure 10. North America Hereditary Cancer Testing Management Market, By Diagnosis Type 2018 & 2027 (%)
Figure 11. North America Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Hereditary Cancer Testing Market, By Technology 2018 & 2027 (%)
Figure 16. North America Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Microarray Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Hereditary Cancer Testing Market, By End User 2018 & 2027 (%)
Figure 20. North America Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Clinics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)
Figure 24. North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)
Figure 26. US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
Figure 30. Organic Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
Figure 31. Inorganic Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019
The List of Companies
- Biosero Inc.
- Hologic Inc.
- Koninklijke Philips N.V.
- Quest Diagnostics Incorporated
- Myriad Genetics, Inc.
- Cancer Genetics Inc.
- Invitae Corporation
- Myogenes
- Strand Life Sciences Pvt. Ltd.
- Pathway Genomics Corporation
- CENTOGENE AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Oct 2019
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
Oct 2019
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
Oct 2019
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
Oct 2019
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2019
Prescription Drugs Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2019
Regenerative Dentistry Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Natural and Synthetic), Technology (Tissue Engineering, Stem Cell Therapy, and Others), Application (Periodontal Regeneration, Endodontic Regeneration, Tooth Reconstruction, Bone Regeneration, and Others), Age Group (Adult and Pediatric), End User (Dental Clinics, Hospital, and Others), and Geography
Oct 2019
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Oct 2019
Cell and Gene Therapy Contract Development and Manufacturing Organization Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography
Get Free Sample For